Inhibition of murine AIDS by pro-glutathione (GSH) molecules

Antiviral Research

Volumn 77, Issue 2, 2008, Pages 120-127

  Fraternale, A ^a   Paoletti, M F ^a   Casabianca, A ^a   Orlandi, C ^a   Schiavano, G F ^a   Chiarantini, L ^a   Clayette, P ^b   Oiry, J ^c   Vogel, J U ^d   Cinatl Jr , J ^e   Magnani, M ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c UNIV MONTPELLIER   (France)

^d Frankfurter Stiftung für Krebskranke Kinder   (Germany)

^e Institute of Medical Virology   (Germany)

Author keywords

Antiretroviral; GSH; MAIDS; Pro GSH molecules

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; GLUTATHIONE DERIVATIVE; I 152; IMMUNOGLOBULIN G; MERCAPTAMINE; PRODRUG; S ACETYLGLUTATHIONE; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DNA CONTENT; DRUG STRUCTURE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; INOCULATION; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MOUSE; MURINE ACQUIRED IMMUNODEFICIENCY VIRUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS; RODENT DISEASE; SPLENOMEGALY; STATISTICAL ANALYSIS; VIRUS INHIBITION; VIRUS LOAD;

ACETYLCYSTEINE; ANIMALS; ANTI-HIV AGENTS; CELL PROLIFERATION; CYSTEAMINE; DISEASE MODELS, ANIMAL; DNA, VIRAL; FEMALE; GLUTATHIONE; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN G; LEUKEMIA VIRUS, MURINE; LYMPH NODES; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; ORGAN SIZE; POLYMERASE CHAIN REACTION; PRODRUGS; SPLEEN;

ANIMALIA; MURINAE; MUS;

EID: 38349063602     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2007.11.004     Document Type: Article

References (47)

1. Aukrust P., Müller F., Svardal A.M., Ueland T., Berge R.K., and Frøland S.S. Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy-potential immunomodulatory effects of antioxidants. J. Infect. Dis. 188 (2003) 232-238
2. Aziz D.C., Hanna Z., and Jolicoeur P. Severe immunodeficiency disease induced by a defective murine leukaemia virus. Nature 338 (1989) 505-508
3. Beilharz M.W., Sammels L.M., Paun A., Shaw K., van Eeden P., Watson M.W., and Ashdown M.L. Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression. J. Immunol. 172 (2004) 4917-4925
4. Casabianca A., Orlandi C., Fraternale A., and Magnani M. Development of a real-time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS. J. Clin. Microbiol. 42 (2004) 4361-4364
5. Cerny A., Hügin A.W., Hardy R.R., Hayakawa K., Zinkernagel R.M., Makino M., and Morse III H.C. B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome. J. Exp. Med. 171 (1990) 315-320
6. De Rosa S.C., Zaretsky M.D., Dubs J.G., Roederer M., Anderson M., Green A., Mitra D., Watanabe N., Nakamura H., Tjioe I., Deresinski S.C., Moore W.A., Ela S.W., Parks D., and Herzenberg L.A. N-acetylcysteine replenishes glutathione in HIV infection. Eur. J. Clin. Invest. 30 (2000) 915-929
7. Dias A.S., Bester M.J., Britz R.F., and Apostolides Z. Animal models used for the evaluation of antiretroviral therapies. Curr. HIV Res. 4 (2006) 431-446
8. Dobashi K., Aihara M., Araki T., Shimizu Y., Utsugi M., Iizuka K., Murata Y., Hamuro J., Nakazawa T., and Mori M. Regulation of LPS induced IL-12 production by IFN-gamma and IL-4 through intracellular glutathione status in human alveolar macrophages. Clin. Exp. Immunol. 124 (2001) 290-296
9. Eylar E., Rivera-Quinones C., Molina C., Báez I., Molina F., and Mercado C.M. N-acetylcysteine enhances T cell functions and T cell growth in culture. Int. Immunol. 5 (1993) 97-101
10. Fraternale A., Tonelli A., Casabianca A., Chiarantini L., Schiavano G.F., Celeste A.G., and Magnani M. New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS. J. Acq. Immune Def. Syndr. 23 (2000) 107-113
11. Fraternale A., Casabianca A., Tonelli A., Chiarantini L., Brandi G., and Magnani M. New drug combinations for the treatment of murine AIDS and macrophage protection. Eur. J. Clin. Invest. 31 (2001) 248-252
12. Fraternale A., Casabianca A., Orlandi C., Cerasi A., Chiarantini L., Brandi G., and Magnani M. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. Antiviral Res. 56 (2002) 263-272
13. Fraternale A., Casabianca A., Orlandi C., Chiarantini L., Brandi G., Silvestri G., and Magnani M. Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels. Virology 302 (2002) 354-362
14. Fraternale A., Paoletti M.F., Casabianca A., Oiry J., Clayette P., Vogel J.-U., Cinatl Jr. J., Palamara A.T., Sgarbanti R., Garaci E., Millo E., Benatti U., and Magnani M. Antiviral and immunomodulatory of new pro-glutathione (GSH) molecules. Curr. Med. Chem. 13 (2006) 1749-1755
15. Garaci E., Palamara A.T., Ciriolo M.R., D'Agostini C., Abdel-Latif M.S., Aquaro S., Lafavia E., and Rotilio G. Intracellular GSH content and HIV replication in human macrophages. J. Leukoc. Biol. 62 (1997) 54-59
16. Giordani L., Quaranta M.G., Malorni W., Boccanera M., Giacomini E., and Viora M. N-acetylcysteine inhibits the induction of an antigen-specific antibody response down-regulating CD40 and CD27 co-stimulatory molecules. Clin. Exp. Immunol. 129 (2002) 254-264
17. Herzenberg L.A., De Rosa S.C., Dubs J.G., Roederer M., Anderson M.T., Ela S.W., Deresinski S.C., and Herzenberg L.A. Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 1967-1972
18. Huang M., Simard C., Kay D.G., and Jolicoeur P. The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J. Virol. 65 (1991) 6562-6571
19. Iijima N., Yanagawa Y., Iwabuchi K., and Onoé K. Selective regulation of CD40 expression in murine dendritic cells by thiol antioxidants. Immunology 110 (2003) 197-205
20. Jeannin P., Delneste Y., Lecoanet-Henchoz S., Gauchat J.F., Life P., Holmes D., and Bonnefoy J.Y. Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis. J. Exp. Med. 182 (1995) 1785-1792
21. Kalebic T., Kinter A., Poli G., Anderson M.E., Meister A., and Fauci A.S. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 986-990
22. Klinman D.M., and Morse III H.C. Characteristics of B cell proliferation and activation in murine AIDS. J. Immunol. 142 (1989) 1144-1149
23. Lu S.C. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J. 13 (1999) 1169-1183
24. Magnani M., Fraternale A., Casabianca A., Schiavano G.F., Chiarantini L., Palamara A.T., Ciriolo M.R., Rotilio G., and Garaci E. Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. AIDS Res. Hum. Retroviruses 13 (1997) 1093-1099
25. Malorni W., Rivabene R., Lucia B.M., Ferrara R., Mazzone A.M., Cauda R., and Paganelli R. The role of oxidative imbalance in progression to AIDS: effect of the thiol supplier N-acetylcysteine. AIDS Res. Hum. Retroviruses 14 (1998) 1589-1596
26. Mayhew C.N., Sumpter R., Inayat M., Cibull M., Phillips J.D., Elford H.L., and Gallicchio V.S. Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease. Antiviral Res. 65 (2005) 13-22
27. Mazzeo D., Sacco S., Di Lucia P., Penna G., Adorini L., Panina-Bordignon P., and Ghezzi P. Thiol antioxidants inhibit the formation of the interleukin-12 heterodimer: a novel mechanism for the inhibition of IL-12 production. Cytokine 17 (2002) 285-293
28. Monick M.M., Samavati L., Butler N.S., Mohning M., Powers L.S., Yarovinsky T., Spitz D.R., and Hunninghake G.W. Intracellular thiols contribute to Th2 function via a positive role in IL-4 production. J. Immunol. 171 (2003) 5107-5115
29. Morse III H.C., Yetter R.A., Via C.S., Hardy R.R., Cerny A., Hayakawa K., Hugin A.W., Miller M.W., Homes K.L., and Shearer G.M. Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndrome. J. Immunol. 143 (1989) 844-850
30. Morse III H.C., Chattopadhyay S.K., Makino M., Fredrickson T.N., Hügin A.W., and Hartley J.W. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6 (1992) 607-621
31. Mosier D.E., Yetter R.A., and Morse III H.C. Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J. Exp. Med. 165 (1987) 1737-1742
32. Murata Y., Shimamura T., and Hamuro J. The polarization of T(h)1/T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int. Immunol. 14 (2002) 201-212
33. Nakamura H., Masutani H., and Yodoi J. Redox imbalance and its control in HIV infection. Antioxid. Redox Signal. 4 (2002) 455-464
34. Nencioni L., Iuvara A., Aquilano K., Circolo M.C., Cozzolino F., Rotilio G., Garaci E., and Palamara A.T. Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2. FASEB J. 17 (2003) 758-760
35. Oiry J., Mialocq P., Puy J.Y., Fretier P., Clayette P., Dormont D., and Imbach J.L. NAC/MEA conjugate: a new potent antioxidant which increases the GSH level in various cell lines. Bioorg. Med. Chem. Lett. 11 (2001) 1189-1191
36. Oiry J., Mialocq P., Puy J.Y., Fretier P., Dereuddre-Bosquet N., Dormont D., Imbach J.L., and Clayette P. Synthesis and biological evaluation in human monocyte-derived macrophages of N-(N-acetyl-l-cysteinyl)-S-acetylcysteamine analogues with potent antioxidant and anti-HIV activities. J. Med. Chem. 47 (2004) 1789-1795
37. Palamara A.T., Garaci E., Rotilio G., Ciriolo M.R., Casabianca A., Fraternale A., Rossi L., Schiavano G.F., Chiarantini L., and Magnani M. Inhibition of murine AIDS by reduced glutathione. AIDS Res. Hum. Retroviruses 12 (1996) 1373-1381
38. Palamara A.T., Brandi G., Rossi L., Millo E., Benatti U., Nencioni L., Iuvara A., Garaci E., and Magnani M. New synthetic glutathione derivatives with increased antiviral activities. Antiviral Chem. Chemother. 15 (2004) 83-91
39. Price T.O., Ercal N., Nakaoke R., and Banks W.A. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res. 1045 (2005) 57-63
40. Price T.O., Uras F., Banks W.A., and Ercal N. A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells. Exp. Neurol. 201 (2006) 193-202
41. Spada C., Treitinger A., Reis M., Masokawa I.Y., Verdi J.C., Luiz M.C., Silveira M.V., Oliveira O.V., Michelon C.M., Avila-Júnior S., Gil D.O., and Ostrowsky S. An evaluation of antiretroviral therapy associated with alpha-tocopherol supplementation in HIV-infected patients. Clin. Chem. Lab. Med. 40 (2002) 456-459
42. Stevens M., Pannecouque C., De Clercq E., and Balzarini J. Pyridine N-oxide derivatives inhibit viral transactivation by interfering with NF-kappaB binding. Biochem. Pharmacol. 71 (2006) 1122-1135
43. Venketaraman V., Rodgers T., Linares R., Reilly N., Swaminathan S., Hom D., Millman A.C., Wallis R., and Connell N.D. Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects. AIDS Res. Ther. 3 (2006) 5
44. Verhasselt V., Vanden Berghe W., Vanderheyde N., Willems F., Haegeman G., and Goldman M. N-acetyl-l-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J. Immunol. 162 (1999) 2569-2574
45. Vogel J.U., Cinatl J., Dauletbaev N., Buxbaum S., Treusch G., Cinatl Jr. J., Gerein V., and Doerr H.W. Effects of S-acetylglutathione in cell and in animal model of herpes simplex virus type 1 infection. Med. Microbiol. Immunol. 194 (2005) 55-59
46. Wendel A., and Cikryt P. The level and half-life of glutathione in human plasma. FEBS Lett. 120 (1980) 209-211
47. Yetter R.A., Buller R.M.L., Lee J.S., Elkins K.L., Mosier D.E., Fredrickson T.N., and Morse III H.C. CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J. Exp. Med 168 (1988) 623-635